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Objectives: To determine the COVID-19 pandemic’s effect on female sexual functions 
among Turkish women. 
Material and methods: The present study was performed by using the previous study data 
that was conducted before the pandemic to detect female sexual function by using 
questionnaires. Comparison of Female Sexual Function Index (FSFI), Beck Anxiety 
Inventory (BAI), and Beck Depression Inventory (BDI) scores in women during and before 
the pandemic. Participants were asked to fill questionnaire forms again. 
Results: FSFI scores of the participants were higher before the pandemic, however, this 
finding was not statistically significant (21.8 vs 21.0, p = 0.27). BAI and BDI scores with 
high scores accompanied by anxiety and depression were found statistically significantly 
higher in the study (11.2 vs 13.3, p < 0.01; 10.0 vs 13.7, p < 0.01; respectively). BAI scores 
had a negative correlation with FSFI scores, however, BDI scores had not a significant 
correlation with FSFI scores in the present study (p < 0.01, correlation coefficient = –0.302; p 
= 0.07; correlation coefficient = –0.183; respectively). 
Conclusions: Pandemic seems not to affect female sexual behavior. However, the pandemic 
is associated with anxiety and depression. 





Coronavirus is a member of the RNA virus family that affect the respiratory system. 
As a result of that, common symptoms are fever, cough, and cold; however, the infection can 
be more serious in certain cases and has resulted in pneumonia and acute respiratory distress 
syndrome [1]. The COVID-19 infection is believed to have first started in China, then 
spreading throughout the world and declared as a pandemic by the World Health Organization 
on 11th March 2020. At the time of writing this article, the confirmed case number was more 
than 33 million and the number of death was more than 997 000. Therefore most of the 
countries and states set strict rules including travel restrictions, closing borders, and 
quarantine [2]. 
Prevalence of female sexual dysfunction (FSD) is approximately 40% among women 
of all ages. Quality of life is impaired by the FSD [3]. Kissinger et al. [4], were determined 
that genital self-care was reduced after Hurricane Katrina. In another study that investigated 
the relationship between sexual behavior and Wenchuan earthquake showed that sexual 
intercourse frequency and satisfaction in women were reduced after the disaster [5]. 
Several studies have investigated the relationship between female sexual function and 
disasters. Few studies have investigated the COVID-19 pandemic effect on sexual behavior. 
However, none of them included all FSFI, Beck anxiety, and Beck depression questionnaires 
that evaluate the female sexual behavior comprehensively. The aim of this study is the 




MATERIAL AND METHODS 
Study design 
From January to February 2020, a cross-sectional and questionnaire-based study was 
conducted to determine the human papillomavirus (HPV) infection effect on female sexual 
behavior at the Department of Obstetrics and Gynecology, Dokuz Eylul University Hospital, 
Izmır, Turkey. The study is under consideration; however, it has not been published yet. 
Healthy controls of the previous study mentioned above were selected for the present study. 
Also, data from the previous study was used. These people were asked if they want to take 
part in this observational study and those who accept this proposal were welcomed. Local 
ethics committee approval was obtained for the study (Ethical approval number: 2020/18–27). 
Written informed consent was obtained from all patients. The patient’s and partner’s age, 
parity, BMI, obstetric history and educational level were recorded. Each participant filled the 
female sexual function index (FSFI), Beck anxiety inventory (BAI), and Beck depression 
inventory (BDI) questionnaires. 
Female participants aged between 18 and 50 were enrolled in the study. Women with 
the psychiatric disorder or taking psychiatric medication, systemic-chronic disease, obesity 
(BMI > 30), pregnancy, pelvic organ prolapse, pelvic surgery that causes FSD, premature 
menopause, dermatologic disorders that affect the genital area, using a medication that 
impaired sexual function such as anti-hypertensive, anti-arrhythmic, sedative drugs were 
excluded from the study. COVID-19 positivity or living with COVID-19 positive or 
suspected individuals were also accepted as an exclusion criterion. 
Questionnaire form 
FSFI questionnaire was applied to the patients. Rosen et al. [6], developed this self–
report questionnaire to detect FSD by evaluating the female sexual functions. There are six 
domains and 19 questions that evaluate arousal, desire, orgasm, lubrication, pain, and 
satisfaction during the last four weeks. 
Better sexual functions are associated with higher scores and scores of each domain 
are in a range between 0 to 5. The first two questions evaluate sexual desire, then arousal by 
the following four questions. The next four questions evaluate lubrication followed by three 
questions evaluating orgasms. There are another three questions to evaluate satisfaction, and 
lastly, the pain is evaluated by the final three questions. The minimum total score is 1.2 and 
the maximum total score is 36 points. FSD was associated with lower scores that imply 
impaired sexual function. The Cronbach alfa coefficient was determined 0.98 in the reliability 
study for the Turkish version of this test. The meaning of this is that FSFI is a valid and 
reliable measure of sexual function among Turkish women. FSD was considered with the 
total scores less than 26. 
BDI includes 21 questions, each of them rating from 0 to 3. Scores from 0 to 9 
indicate no depression, 10 to 18 mean mild to moderate depression, 19 to 29 show moderate 
to severe depression, and scores between 30–63 are related to severe depression [7]. 
BAI consists of 21 questions rating from 0–3. Scores from 0 to 7 indicate minimal 
anxiety, 8 to 15 mean mild anxiety, 16 to 25 show moderate anxiety, and scores between 26 
and 63 correspond to severe anxiety [8]. 
Statistical analysis 
The Kolmogorov-Smirnov test was performed as the normality test. Differences 
between variables were determined by using the paired t-test. Statistic results for continuous 
variables were presented as means ± SD. P < 0.05 was considered statistically significant. 
IBM SPSS Statistics Version 25 was used to analyze the data. 
 
RESULTS 
Ninety-nine sexually active females were enrolled in this study. The mean age of the 
participants and their partners were 35.1 and 36.7, respectively. The mean BMI was 26.8 and 
the mean parity rate was 1.8. Socio-demographic data is summarized in Table 1. 
 FSFI scores of the participants were higher before the pandemic, however, this finding 
was not statistically significant (21.8 vs 21.0, p = 0.27). All of the domains of the FSFI 
(desire, arousal, lubrication, orgasm) were determined lower during the pandemic except 
satisfaction and pain. Satisfaction and pain scores were determined to be the same before and 
during the pandemic. However, there was no statistically significant difference (3.5 vs 3.3, p 
= 0.20; 3.5 vs 3.3, p = 0.08; 3.7 vs 3.5, p = 0.22; 3.5 vs 3.4, p = 0.50; 4.0 vs 4.0, p = 0.67; 3.3 
vs 3.3, p = 0.93) (Tab. 2). 
 Comparison of BAI scores to detect whether there is a relationship between anxiety 
and pandemic showed that the anxiety levels seem significantly increased during the 
pandemic (11.2 vs 13.3, p < 0.01). Additionally, during the pandemic, the BDI score of which 
higher scores indicate depression were determined increased statistically significant (10.0 vs 
13.7, p < 0.01) (Tab. 3). Although both increased anxiety and depression, FSFI scores did not 
decrease significantly during the pandemic.  
 When the evaluation of whether there is a relation between BAI and FSFI scores, a 
statistically significant negative correlation was found between BAI and FSFI scores (p < 
0.01; correlation coefficient = –0.302). FSFI scores had a decremental pattern while the BAI 
scores were increasing. However, statistically significant correlation was not found between 
BDI and FSFI scores (p = 0.07; correlation coefficient = –0.183) 
 
DISCUSSION 
The COVID-19 pandemic has caused a deterioration in social life via elongated 
quarantine time, disrupted relations between people, increased anxiety, and depression. 
Evaluation of female sexual function and the possible factors that affect female sexual 
behavior during the pandemic were the of this study. Despite the increased anxiety and 
depression, female sexual function was not found significantly different during the pandemic 
in comparison to before the pandemic.  
Stress is one of the main factors that affect sexual desire. However, literature has 
studies with different results on this issue. Chronic stress or natural disasters such as 
earthquakes were found to harm female sexual behavior [5, 9]. By contrast, another study 
conducted by Hall et al. [10], has a result of that women has better sexual activity during 
stressful times. This may be the result of spending more time with their partners at home. 
It was shown in previous studies that natural disasters and war impacts female sexual 
function negatively . In a study that investigated the sexual behavior after a tsunami has a 
result that 30% of 1093 participants were suffering from sexual dysfunction [11]. However, in 
this study a validated FSFI questionnaire was not used. Reduced desire, decreased lubrication, 
and difficulties to achieve orgasm were the main results of a study that was conducted on 
female soldiers [12]. The present study is the first study that investigated the female sexual 
behavior and COVID-19 pandemic relation by using BAI and BDI, in addition to FSFI to our 
knowledge. Although FSFI scores were found to have decreased in the present study, this was 
not statistically significant. Also, alteration of all domains of FSFI including desire, arousal, 
lubrication, orgasm, satisfaction, and pain before and after the pandemic were not found 
statistically significant. 
Studies show that anxiety and depression has increased during the Covid-19 pandemic 
[13–15]. In a study conducted by Yeen Huang et al. [16], showed that the prevalence of 
generalized anxiety disorder and depressive symptoms were 35.1% and 20.1%, respectively, 
in the pandemic period. The relationship between depression and female sexual disorder is a 
well-known fact. Sreelakshmy et al. [17], showed that FSD rates were higher in people with 
depression regardless of severity and type. BDI was a widely used questionnaire in studies to 
evaluate whether there was a relationship between sexual function and depression [18, 19]. 
On the other hand, women with anxiety have inhibited sexuality [20]. The ten-times common 
domain of FSD was pain in anxiety disorder [21]. BAI was also a commonly used, validated 
questionnaire in the studies that investigated the link between anxiety and sexual disorder [22, 
23]. In our study, anxiety and depression symptoms seemed significantly increased during the 
pandemic. Also, a negative correlation was found between FSFI and BAI, as expected. 
However, a statistically significant correlation was not found between BDI and FSFI scores. 
The first limitation of the study is that male partners, who can affect sexual behavior, were not 
included in this study. Additionally, the present study investigated the short term results of the 
pandemic’s effect on female emotions and sexual behavior, different results may be produced 
with the increased restrictions and elongated pandemic process. On the other hand, the 
strength of the present study is the investigation of the anxiety and depression status of the 
participants that can affect sexual behavior in addition to sexual functions. 
 
CONCLUSIONS 
In conclusion, this study demonstrated that women’s sexual behavior was not significantly 
different during the pandemic. However, depressive symptoms and anxiety have increased 
during the pandemic and the anxiety was determined had a negative correlation with female 
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Table 1. Socio-demographic characteristics of the patients  
 Study group 
N: 52 
Age [y] 35.1 ± 5.8 
BMI [kg/m²] 26.8 ± 3.8 
Number of children 1.8 ± 0.6 
Type of delivery, n (%) 
Vaginal birth 43 (43.4) 
Cesarean section 56 (56.6) 
Educational level, N (%) 




High school 63 (63.6) 
University 17 (17.2) 
Partner’s age [y] 36.7 ± 6 
Results are presented as mean ± SD and number (percentage); BMI — body mass index; SD 
— standard deviation  
 
 
Table 2. FSFI scores comparison of the participants before and after the COVID-19 pandemic 
 Before the pandemic During the pandemic p value 
Total FSFI score 21.8 21.0 0.27 
Desire 3.5 3.3 0.20 
Arousal 3.5 3.3 0.08 
Lubrication  3.7 3.5 0.22 
Orgasm  3.5 3.4 0.50 
Satisfaction  4.0 4.0 0.67 
Pain 3.3 3.3 0.93 
Results are presented as mean and number (percentage); FSFI — Female Sexual Function 
Index 
 
Table 3. BAI and BDI scores of the participants before and during the COVID-19 pandemic 
 Before the pandemic During the pandemic p value 
BAI score 11.2 13.3 < 0.01* 
BDI score 10.0 13.7 < 0.01* 
Results are presented as mean and number (percentage); BAI — Beck Anxiety Inventory; 
BDI — Beck Depression Inventory 
